Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

53%

9 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (2)
P 1 (1)
P 2 (3)
P 3 (1)
P 4 (8)

Trial Status

Completed13
Unknown2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06064591Completed

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

NCT07403643Phase 4Not Yet RecruitingPrimary

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

NCT05911828Phase 1RecruitingPrimary

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

NCT06300970Phase 4Completed

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

NCT04767217Phase 4CompletedPrimary

Malaria Therapeutic Efficacy Study, Rwanda

NCT04767191Phase 4CompletedPrimary

Malaria Therapeutic Efficacy Study (TES) Kenya

NCT06036030Phase 2Completed

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

NCT05192265Phase 2Completed

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

NCT02787070Phase 4CompletedPrimary

A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)

NCT03387631CompletedPrimary

Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania

NCT01213433Phase 4CompletedPrimary

Amodiaquine+Artesunate for Uncomplicated Malaria Treatment

NCT00845533Phase 4CompletedPrimary

Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso

NCT00868465Not ApplicableCompletedPrimary

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)

NCT00459615Phase 2Completed

Phase II Dose Ranging Study of Artesunate

NCT00460369Not ApplicableCompletedPrimary

Treatment of Uncomplicated Malaria in Benin

NCT00540202Phase 4UnknownPrimary

Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children

NCT00406146Phase 3UnknownPrimary

Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children

Showing all 17 trials

Research Network

Activity Timeline